SL
COLL icon

Salomon & Ludwin’s Collegium Pharmaceutical COLL Stock Holding History

Salomon & Ludwin’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.59K Sell
128
-111
-46% -$3.79K ﹤0.01% 1845
2026
Q1 		$7.72K Hold
239
– – ﹤0.01% 1616
2025
Q4 		$10.9K Buy
239
+111
+87% +$4.64K ﹤0.01% 1384
2025
Q3 		$4.43K Buy
+128
New +$4.45K ﹤0.01% 1766

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Salomon & Ludwin's COLL Position: Q2 2026 in Review

Salomon & Ludwin reduced its Collegium Pharmaceutical (COLL) stake by 46% in Q2 2026, selling an estimated $3.79K and leaving 128 shares worth $4.59K. The position accounts for ﹤0.01% of the portfolio, ranked #1845.

Salomon & Ludwin first reported a position in COLL in Q3 2025 and has held it in 4 quarters since. The position peaked at $10.9K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Salomon & Ludwin held 128 shares of Collegium Pharmaceutical worth $4.59K as of Q2 2026.
  • Salomon & Ludwin sold 111 Collegium Pharmaceutical shares in Q2 2026, an estimated $3.79K.
  • Collegium Pharmaceutical made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1845 holding.
  • Salomon & Ludwin first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • Salomon & Ludwin's Collegium Pharmaceutical position peaked at $10.9K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.